These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30514699)

  • 1. Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro.
    Popat RJ; Robson MG
    Ann Rheum Dis; 2019 May; 78(5):709-711. PubMed ID: 30514699
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies in ANCA-associated vasculitis.
    Wiik AS
    Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
    Kettritz R
    Clin Exp Immunol; 2012 Sep; 169(3):220-8. PubMed ID: 22861361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2.
    Cohen Tervaert JW
    Nephrol Dial Transplant; 2019 Mar; 34(3):384-387. PubMed ID: 30668794
    [No Abstract]   [Full Text] [Related]  

  • 5. Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 1.
    Watts RA
    Nephrol Dial Transplant; 2019 Mar; 34(3):381-383. PubMed ID: 30668750
    [No Abstract]   [Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic autoantibodies: an unbiased and efficient tool to classify renal vasculitis? Comment on the article by Lionaki et al.
    Corral-Gudino L
    Arthritis Rheum; 2013 May; 65(5):1405-6. PubMed ID: 23400524
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of dual anti-MPO and anti-PR3 antibodies in Systemic Lupus Erythematosus/ANCA-Associated Vasculitis.
    Fernando SL; Boyle T
    J Clin Pathol; 2020 Oct; 73(10):687-688. PubMed ID: 32513843
    [No Abstract]   [Full Text] [Related]  

  • 9. [NETs in pathogenesis of vasculitis].
    Nakazawa D; Nishio S; Tomaru U; Atsumi T; Ishizu A
    Nihon Jinzo Gakkai Shi; 2014; 56(2):117-23. PubMed ID: 24730349
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the endothelium in systemic small vessel vasculitis.
    Little MA; Savage CO
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S135-40. PubMed ID: 18799071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system.
    Little MA; Al-Ani B; Ren S; Al-Nuaimi H; Leite M; Alpers CE; Savage CO; Duffield JS
    PLoS One; 2012; 7(1):e28626. PubMed ID: 22247758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing Immunoglobulins: The Formation of Pauci-Immune Lesions in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Futamata E; Masuda S; Nishibata Y; Tanaka S; Tomaru U; Ishizu A
    Nephron; 2018; 138(4):328-330. PubMed ID: 29268266
    [No Abstract]   [Full Text] [Related]  

  • 13. L8. Animal models of ANCA associated vasculitis: the contribution of autoantibodies and autoreactive T cells.
    Heeringa P
    Presse Med; 2013 Apr; 42(4 Pt 2):515-7. PubMed ID: 23453995
    [No Abstract]   [Full Text] [Related]  

  • 14. L27. Antibodies versus phenotypes: a clinician's view.
    Jayne D
    Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
    [No Abstract]   [Full Text] [Related]  

  • 15. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcgamma receptors.
    Hussain A; Pankhurst T; Goodall M; Colman R; Jefferis R; Savage CO; Williams JM
    Immunology; 2009 Oct; 128(2):236-44. PubMed ID: 19740380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L26. How antigens influence the disease: an immunologist point of view.
    Free ME; Ciavatta DJ; Falk RJ
    Presse Med; 2013 Apr; 42(4 Pt 2):577-9. PubMed ID: 23454000
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
    Surmiak M; Kaczor M; Sanak M
    J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
    Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
    J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.